Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A
Blood Vessels, Thrombosis & Hemostasis · 2026-11 · 3 (4) · 100195
DOI: 10.1016/j.bvth.2026.100195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-11. Verfasst von Ming Y Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
- Section of Medical Oncology and Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
- Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT.
- Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT.
- Informatics, Decision-Enhancement, and Analytic Sciences Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT.
- Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT.
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- National Heart, Lung, and Blood Institute
- National Cancer Institute
- Yale Cancer Center
- Frederick A. DeLuca Foundation
Zitieren
APA
Lim, M. Y., Ito, S., Goshua, G., Chaiyakunapruk, N., Yoo, M., & Nelson, R. (2026). Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A. Blood Vessels, Thrombosis & Hemostasis, 3(4), 100195. https://doi.org/10.1016/j.bvth.2026.100195
Vancouver
Lim MY, Ito S, Goshua G, Chaiyakunapruk N, Yoo M, Nelson R. Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A. Blood Vessels, Thrombosis & Hemostasis. 2026;3(4):100195. doi:10.1016/j.bvth.2026.100195
BibTeX
@article{Lim2026,
author = {Lim, Ming Y and Ito, Satoko and Goshua, George and Chaiyakunapruk, Nathorn and Yoo, Minkyoung and Nelson, Richard},
title = {Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A},
journal = {Blood Vessels, Thrombosis & Hemostasis},
year = {2026},
volume = {3},
number = {4},
pages = {100195},
doi = {10.1016/j.bvth.2026.100195}
}
EUVIMED